Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA approves Simponi Aria for psoriatic arthritis and ankylosing spondylitis

Oct. 23, 2017

Novel griseofulvin derivatives discovered by Daiichi Sankyo

Oct. 18, 2017

FDA approves Zilretta for osteoarthritis knee pain

Oct. 9, 2017

DiscGenics cleared to begin clinical testing of IDCT in U.S.

Oct. 4, 2017

FDA grants rare pediatric disease and fast track designations to Audentes' AT-132

Sep. 28, 2017

Acer Therapeutics reports results from pivotal study of Edsivo in vascular Ehlers-Danlos syndrome

Sep. 27, 2017

Pluristem planning phase III study of PLX-PAD cells for muscle recovery after arthroplasty

Sep. 27, 2017

Medivir reports promising topline data on MIV-711 in knee osteoarthritis

Sep. 27, 2017

Janssen Biotech receives complete response letter for sirukumab BLA

Sep. 26, 2017

ImmuPharma offers update on Lupuzor program

Sep. 26, 2017

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...